Logo image of ESF0.DE

EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis

FRA:ESF0 - Deutsche Boerse Ag - FR0014000MR3 - Common Stock - Currency: EUR

49.02  -1.5 (-2.97%)

Fundamental Rating

5

ESF0 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 15 industry peers in the Life Sciences Tools & Services industry. ESF0 has an excellent profitability rating, but there are some minor concerns on its financial health. ESF0 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ESF0 was profitable.
ESF0 had a positive operating cash flow in the past year.
In the past 5 years ESF0 has always been profitable.
In the past 5 years ESF0 always reported a positive cash flow from operatings.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

ESF0 has a better Return On Assets (3.24%) than 73.33% of its industry peers.
ESF0's Return On Equity of 6.61% is fine compared to the rest of the industry. ESF0 outperforms 66.67% of its industry peers.
ESF0 has a Return On Invested Capital of 9.18%. This is in the better half of the industry: ESF0 outperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ESF0 is in line with the industry average of 6.90%.
The last Return On Invested Capital (9.18%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.24%
ROE 6.61%
ROIC 9.18%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 5.08%, ESF0 perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
ESF0's Profit Margin has improved in the last couple of years.
The Operating Margin of ESF0 (14.97%) is better than 73.33% of its industry peers.
In the last couple of years the Operating Margin of ESF0 has grown nicely.
ESF0 has a Gross Margin of 22.33%. This is in the lower half of the industry: ESF0 underperforms 73.33% of its industry peers.
In the last couple of years the Gross Margin of ESF0 has grown nicely.
Industry RankSector Rank
OM 14.97%
PM (TTM) 5.08%
GM 22.33%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESF0 is creating some value.
ESF0 has less shares outstanding than it did 1 year ago.
ESF0 has more shares outstanding than it did 5 years ago.
ESF0 has a better debt/assets ratio than last year.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.51 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
ESF0 has a Altman-Z score of 2.51. This is in the lower half of the industry: ESF0 underperforms 60.00% of its industry peers.
The Debt to FCF ratio of ESF0 is 4.57, which is a neutral value as it means it would take ESF0, 4.57 years of fcf income to pay off all of its debts.
ESF0 has a Debt to FCF ratio of 4.57. This is in the better half of the industry: ESF0 outperforms 66.67% of its industry peers.
ESF0 has a Debt/Equity ratio of 0.59. This is a neutral value indicating ESF0 is somewhat dependend on debt financing.
ESF0 has a Debt to Equity ratio (0.59) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.57
Altman-Z 2.51
ROIC/WACC1.31
WACC6.99%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.16 indicates that ESF0 should not have too much problems paying its short term obligations.
ESF0 has a worse Current ratio (1.16) than 73.33% of its industry peers.
A Quick Ratio of 1.09 indicates that ESF0 should not have too much problems paying its short term obligations.
ESF0's Quick ratio of 1.09 is in line compared to the rest of the industry. ESF0 outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.09
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.63% over the past year.
The Earnings Per Share has been growing by 18.34% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.70% in the past year.
Measured over the past years, ESF0 shows a quite strong growth in Revenue. The Revenue has been growing by 8.78% on average per year.
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%13.46%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%

3.2 Future

ESF0 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.23% yearly.
Based on estimates for the next years, ESF0 will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y15.29%
EPS Next 2Y14.58%
EPS Next 3Y14%
EPS Next 5Y14.23%
Revenue Next Year7.56%
Revenue Next 2Y7.24%
Revenue Next 3Y7.28%
Revenue Next 5Y6.02%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.23, which means the current valuation is very expensive for ESF0.
ESF0's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.64, ESF0 is valued at the same level.
ESF0 is valuated correctly with a Price/Forward Earnings ratio of 13.77.
ESF0's Price/Forward Earnings ratio is rather cheap when compared to the industry. ESF0 is cheaper than 93.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ESF0 to the average of the S&P500 Index (21.44), we can say ESF0 is valued slightly cheaper.
Industry RankSector Rank
PE 27.23
Fwd PE 13.77
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaper than 93.33% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ESF0 indicates a rather cheap valuation: ESF0 is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.3
EV/EBITDA 6.88
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ESF0 may justify a higher PE ratio.
ESF0's earnings are expected to grow with 14.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.78
PEG (5Y)1.49
EPS Next 2Y14.58%
EPS Next 3Y14%

4

5. Dividend

5.1 Amount

ESF0 has a Yearly Dividend Yield of 1.21%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.92, ESF0 pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.52, ESF0's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years0
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

27.77% of the earnings are spent on dividend by ESF0. This is a low number and sustainable payout ratio.
ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.77%
EPS Next 2Y14.58%
EPS Next 3Y14%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

FRA:ESF0 (4/22/2025, 7:00:00 PM)

49.02

-1.5 (-2.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-30 2025-01-30/bmo
Earnings (Next)04-23 2025-04-23
Inst Owners33.4%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap8.93B
Analysts68.42
Price Target59.63 (21.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP27.77%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.35%
PT rev (3m)-0.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.05%
EPS NY rev (3m)1.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 27.23
Fwd PE 13.77
P/S 1.28
P/FCF 11.3
P/OCF 6.77
P/B 1.67
P/tB N/A
EV/EBITDA 6.88
EPS(TTM)1.8
EY3.67%
EPS(NY)3.56
Fwd EY7.26%
FCF(TTM)4.34
FCFY8.85%
OCF(TTM)7.24
OCFY14.77%
SpS38.16
BVpS29.31
TBVpS-1.59
PEG (NY)1.78
PEG (5Y)1.49
Profitability
Industry RankSector Rank
ROA 3.24%
ROE 6.61%
ROCE 11.86%
ROIC 9.18%
ROICexc 9.87%
ROICexgc 31.79%
OM 14.97%
PM (TTM) 5.08%
GM 22.33%
FCFM 11.37%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexcg growth 3Y-18.17%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score8
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.57
Debt/EBITDA 1.81
Cap/Depr 76.4%
Cap/Sales 7.6%
Interest Coverage 9.11
Cash Conversion 76.13%
Profit Quality 224%
Current Ratio 1.16
Quick Ratio 1.09
Altman-Z 2.51
F-Score8
WACC6.99%
ROIC/WACC1.31
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%13.46%
EPS Next Y15.29%
EPS Next 2Y14.58%
EPS Next 3Y14%
EPS Next 5Y14.23%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%
Revenue Next Year7.56%
Revenue Next 2Y7.24%
Revenue Next 3Y7.28%
Revenue Next 5Y6.02%
EBIT growth 1Y23.67%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year87.36%
EBIT Next 3Y30.94%
EBIT Next 5Y22.77%
FCF growth 1Y68.95%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y29.56%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%